Rakuten Investment Management Inc. Buys 82,964 Shares of GE HealthCare Technologies Inc. $GEHC

Rakuten Investment Management Inc. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3,607.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 85,264 shares of the company’s stock after acquiring an additional 82,964 shares during the period. Rakuten Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $7,090,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in GEHC. Empowered Funds LLC boosted its position in shares of GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $259,000. Cresset Asset Management LLC boosted its position in shares of GE HealthCare Technologies by 12.5% during the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after purchasing an additional 865 shares in the last quarter. Jump Financial LLC boosted its position in shares of GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after purchasing an additional 21,396 shares in the last quarter. Finally, Gamco Investors INC. ET AL increased its stake in GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after purchasing an additional 320 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other news, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The stock was acquired at an average cost of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Peter J. Arduini acquired 4,169 shares of GE HealthCare Technologies stock in a transaction on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 21,847 shares of company stock worth $1,361,355 in the last ninety days. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Stock Down 2.4%

GEHC stock opened at $63.23 on Wednesday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock’s 50 day moving average is $66.07 and its 200-day moving average is $74.95. The firm has a market capitalization of $28.76 billion, a PE ratio of 15.13, a P/E/G ratio of 1.76 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the business earned $1.01 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research reports. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Jefferies Financial Group lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Finally, Piper Sandler decreased their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.